Novo Nordisk A/S (NVO)
NYSE: NVO
· Real-Time Price · USD
74.66
2.01 (2.77%)
At close: Jun 06, 2025, 3:59 PM
74.70
0.05%
After-hours: Jun 06, 2025, 05:58 PM EDT
Revenue by Geography
| Period Ending | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 |
|---|---|---|---|
| Emea Revenue | 50.87B | 44.24B | 37.71B |
| Emea Revenue Growth | +14.99% | +17.32% | n/a |
| North America Revenue | 136.63B | 91.11B | 67.26B |
| North America Revenue Growth | +49.97% | +35.45% | n/a |
| Rest Of World Revenue | 28.08B | 25.4B | 19.81B |
| Rest Of World Revenue Growth | +10.53% | +28.22% | n/a |
Operating Expense Breakdown
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 16.11B | 20.28B | 16.59B | 16.09B | 14.41B | 18.63B | 14.07B | 15.41B | 13.48B | 15.09B | 12.61B | 11.83B | 11.15B | 12.82B | 10.14B | 8.9B | 9.19B | 10.96B | 9.18B | 8.22B | 8.52B | 10.77B | 8.77B | 8.43B | 7.86B | 10B | 8.06B | 7.94B | 7.32B | 9.41B | 7.39B | 7.62B | 7.7B | 9.07B | 7.88B | 7.74B | 7.65B | 9.2B | 7.9B | 8.06B | 7B |
| Selling, General, and Administrative Revenue Growth | -20.56% | +22.23% | +3.11% | +11.64% | -22.62% | +32.33% | -8.69% | +14.32% | -10.66% | +19.68% | +6.58% | +6.08% | -13.02% | +26.41% | +13.90% | -3.08% | -16.20% | +19.43% | +11.61% | -3.43% | -20.93% | +22.82% | +4.01% | +7.32% | -21.41% | +24.03% | +1.50% | +8.56% | -22.29% | +27.32% | -2.95% | -1.06% | -15.15% | +15.24% | +1.74% | +1.19% | -16.89% | +16.45% | -1.97% | +15.15% | n/a |
| Research and Development Revenue | 10.31B | 13.8B | 9.49B | 16.17B | 8.61B | 10.46B | 8.13B | 7.13B | 6.73B | 8.09B | 5.63B | 5.12B | 5.21B | 5.63B | 4.25B | 3.94B | 3.94B | 4.48B | 3.91B | 3.29B | 3.78B | 4.38B | 3.6B | 3.56B | 2.68B | 4.54B | 3.64B | 3.3B | 3.32B | 3.98B | 3.33B | 3.41B | 3.29B | 4.47B | 3.46B | 3.33B | 3.3B | 4.03B | 3.29B | 3.04B | 3.25B |
| Research and Development Revenue Growth | -25.32% | +45.47% | -41.31% | +87.85% | -17.72% | +28.69% | +14.05% | +5.93% | -16.78% | +43.53% | +9.96% | -1.59% | -7.56% | +32.46% | +7.81% | 0.00% | -12.02% | +14.63% | +18.84% | -12.87% | -13.85% | +21.74% | +1.24% | +32.82% | -41.07% | +24.70% | +10.56% | -0.75% | -16.62% | +19.68% | -2.52% | +3.80% | -26.42% | +29.27% | +3.81% | +0.82% | -18.10% | +22.65% | +8.37% | -6.62% | n/a |
| Sales and Marketing Revenue | 14.89B | 18.7B | 15.21B | 14.93B | 13.26B | 17.17B | 12.82B | 14.34B | 12.41B | 13.74B | 11.45B | 10.84B | 10.18B | 11.63B | 9.12B | 8B | 8.26B | 9.77B | 8.17B | 7.4B | 7.59B | 9.54B | 7.76B | 7.58B | 6.95B | 8.73B | 7.13B | 7.09B | 6.45B | 8.29B | 6.5B | 6.76B | 6.79B | 7.91B | 6.86B | 6.87B | 6.74B | 8.04B | 6.95B | 7.17B | 6.15B |
| Sales and Marketing Revenue Growth | -20.37% | +22.95% | +1.85% | +12.66% | -22.80% | +33.94% | -10.62% | +15.55% | -9.68% | +20.02% | +5.64% | +6.45% | -12.46% | +27.56% | +13.97% | -3.09% | -15.46% | +19.48% | +10.49% | -2.53% | -20.41% | +22.87% | +2.39% | +9.13% | -20.42% | +22.45% | +0.54% | +9.91% | -22.23% | +27.67% | -3.90% | -0.38% | -14.19% | +15.29% | -0.10% | +1.87% | -16.15% | +15.65% | -3.12% | +16.72% | n/a |